The Indian Council of Medical Research (ICMR) study that found no advantages of improving plasma treatment for Covid-19 patients was published in the companion looked into British Medical Journal on Thursday. The investigation reasoned that the treatment didn’t forestall movement to extreme disease among Covid-19 patients.

It found that the results were nearly the equivalent for the two groups – 235 who got two doses of recovering plasma and 229 who got the standard consideration.

The treatment includes the use of plasma of individuals, who have recouped from the contamination, to help the safe reaction of those as yet battling it.

The finding of the investigation has been referred to as one reason the National Task Force is thinking about eliminating plasma treatment from the standard Covid-19 treatment protocol.

Delhi health minister Satyendra Jain has supported the therapy having received it himself. “A study done by ICMR and AIIMS [All India Institute of Medical Sciences] did not see any breakthrough maybe. But our trial is underway and it is of course being done with the permission of ICMR. We have seen benefits of the therapy, with over 2,000 people having received convalescent plasma from our bank… I have myself benefited from the therapy,” Jain said this week.

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Buzz Illustrated journalist was involved in the writing and production of this article.